Skip to main content
Premium Trial:

Request an Annual Quote

23andMe: Valerie Montgomery Rice, Peter Taylor

23andMe has appointed Valerie Montgomery Rice and Peter Taylor to its board of directors following the June 16 closing of the previously announced business combination between 23andMe and VG Acquisition Corp.

Montgomery Rice is currently president and dean of Morehouse School of Medicine. An infertility specialist and researcher, she has held faculty positions and leadership roles at various health centers, and most notably was the founding director of the Center for Women's Health Research at Meharry Medical College, a research center devoted to studying diseases that disproportionately impact women of color.

Taylor is president of the non-profit ECMC Foundation, where he has led more than $195 million of grant and investment initiatives affecting educational outcomes, especially among underserved populations. Taylor has also served as executive vice president and CFO for the University of California system, and he previously spent 16 years in the investment banking industry including with Lehman Brothers and Barclays Capital.

The Scan

Review of Approval Process

Stat News reports the Department for Health and Human Services' Office of the Inspector General is to investigate FDA's approval of Biogen's Alzheimer's disease drug.

Not Quite Right

A new analysis has found hundreds of studies with incorrect nucleotide sequences reported in their methods, according to Nature News.

CRISPR and mRNA Together

Time magazine reports on the use of mRNA to deliver CRISPR machinery.

Nature Papers Present Smartphone Platform for DNA Diagnosis of Malaria, Mouse Lines for Epigenomic Editing

In Nature this week: a low-cost tool to detect infectious diseases like malaria, and more.